IFLR1000

Boston Scientific $4.2 billion acquisition of BTG

1/12/2018
Public acquisition
Select tab

$ 4.2 billion

Announced

1/12/2018

Overview:

  • Boston Scientific Corporation has made a recommended cash offer for the entire issued share capital of BTG, at a price of approximately $4.2 billion (£3.3 billion).
  • The acquisition is intended to be implemented by way of a scheme of arrangement with financing in part by way of a £3.3 billion bridge credit agreement between Boston Scientific and Barclays Bank.

Jurisdictions:

United States
United Kingdom

Deal type:

Public acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firms:
Shearman & Sterling

Party: Boston Scientific (Acquirer)

Lawyer: Clare O'Brien

Simpson Thacher & Bartlett

Party: Barclays (Lender)

Lawyer: Patrick Ryan

Related deals